A schematic cut-away of facial skin with a melasma patch, not to scale. A thin film of Melzara Cream lies on the surface. In the epidermis, melanocytes sit on the basement membrane and reach between keratinocytes with branching dendrites; melanin passes along the dendrites into the keratinocytes, where it forms dark caps over their nuclei, so the patch looks brown. Below, the dermis shows signs that come with melasma: clumped sun-damaged elastic fibres (solar elastosis), a gap in the basement membrane with pigment-filled melanophages beneath it, dilated vessels and mast cells. A sun badge marks UV exposure. Each active is a coloured shape that travels from the film: azelaic acid a diamond, niacinamide a triangle and tranexamic acid a square.
Inset A enlarges a melanocyte. Inside a maturing melanosome, the enzyme tyrosinase makes melanin; azelaic acid docks on tyrosinase and the melanosome stays paler. At a dendrite tip, melanosomes are handed over to a keratinocyte; niacinamide sits at that site and fewer melanosomes cross.
Inset B enlarges a basal keratinocyte under UV. Plasminogen binds lysine sites on its surface and becomes plasmin, and the cell sends prostaglandin E₂ and α-MSH signals to a melanocyte receptor. Tranexamic acid, a lysine analogue, keeps plasminogen off those sites, so the signal falls.
The buttons below turn each active on or off in a teaching model. Without azelaic acid, melanin synthesis stays high; without niacinamide, more melanosomes are transferred; without tranexamic acid, the keratinocyte signal and the dilated vessels stay. These are directions of effect, not measured amounts.